Related Experiment Videos
Neurotrophic factor S100 beta in major depression.
H J Grabe1, N Ahrens, H J Rose
1Department of Psychiatry, Klinikum der Hansestadt Stralsund, Ernst Moritz Arndt University of Greifswald, Stralsund, Germany.
Neuropsychobiology
|August 8, 2001
Summary
Depressive disorders may involve the neurotrophic factor S100 beta. Cerebrospinal fluid S100 beta levels were elevated in patients with mild to moderate depressive episodes, suggesting a link between S100 beta and depression.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Serotonergic system dysfunction is linked to depressive disorders.
- The neurotrophic factor S100 beta's role in serotonergic synapse regeneration is hypothesized but unstudied in depression.
- S100 beta may be a potential biomarker for depressive disorders.
Purpose of the Study:
- To investigate the association between cerebrospinal fluid (CSF) S100 beta levels and mild to moderate depressive episodes.
- To explore the potential role of S100 beta in the pathophysiology of depression.
Main Methods:
- CSF S100 beta concentrations were measured in 11 patients diagnosed with mild/moderate depressive episodes (DSM-IV).
- CSF S100 beta concentrations were measured in 11 matched control patients.
- A paired samples t-test was used to compare S100 beta levels between groups.
Main Results:
- Patients with depressive episodes showed significantly elevated CSF S100 beta concentrations compared to controls (t = 2.6, d.f. = 10, p = 0.024).
- This finding suggests a positive correlation between S100 beta levels and the presence of a depressive episode.
Conclusions:
- Elevated CSF S100 beta is associated with mild to moderate depressive episodes.
- Further research, including studies on severely depressed patients, is needed to confirm the role of S100 beta in depressive disorders.
- S100 beta may serve as a potential biomarker for depression.